MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 160 filers reported holding MERIDIAN BIOSCIENCE INC in Q3 2014. The put-call ratio across all filers is 4.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $5,710,000 | +25.5% | 413,745 | +60.9% | 0.95% | +22.3% |
| Q4 2016 | $4,551,000 | +362.0% | 257,120 | +438.2% | 0.78% | +288.1% |
| Q1 2016 | $985,000 | +4.6% | 47,775 | +4.0% | 0.20% | -3.4% |
| Q4 2015 | $942,000 | +20.3% | 45,927 | +0.3% | 0.21% | +18.2% |
| Q3 2015 | $783,000 | -2.5% | 45,805 | +6.3% | 0.18% | -3.3% |
| Q2 2015 | $803,000 | +1.3% | 43,087 | +3.6% | 0.18% | -1.1% |
| Q1 2015 | $793,000 | +86.2% | 41,577 | +60.6% | 0.18% | +85.9% |
| Q4 2014 | $426,000 | -2.1% | 25,883 | +5.3% | 0.10% | -6.6% |
| Q3 2014 | $435,000 | -10.7% | 24,575 | +4.1% | 0.11% | -5.4% |
| Q2 2014 | $487,000 | -2.4% | 23,605 | +3.0% | 0.11% | -6.7% |
| Q1 2014 | $499,000 | +26.0% | 22,909 | +53.4% | 0.12% | +26.3% |
| Q4 2013 | $396,000 | +20.4% | 14,933 | +7.3% | 0.10% | +10.5% |
| Q3 2013 | $329,000 | +23.7% | 13,912 | +12.6% | 0.09% | +13.2% |
| Q2 2013 | $266,000 | – | 12,359 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYQUANT CAPITAL SAS | 134,804 | $4,477 | 11.01% |
| Vazirani Asset Management LLC | 115,774 | $3,845 | 6.51% |
| FIFTH LANE CAPITAL, LP | 185,914 | $6,174,204 | 5.56% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,939,075 | $64,396,681 | 5.01% |
| Crystalline Management Inc. | 244,453 | $8,118,284 | 4.08% |
| FNY Investment Advisers, LLC | 51,000 | $1,693 | 2.36% |
| HAVENS ADVISORS LLC | 26,800 | $890,028 | 2.26% |
| Euclidean Technologies Management, LLC | 62,995 | $2,092,064 | 1.99% |
| Sand Grove Capital Management LLP | 537,060 | $17,836 | 1.70% |
| Crabel Capital Management, LLC | 120,337 | $3,996 | 1.45% |